Sandoz Group
ISIN CH1243598427
|WKN A3ETYB
Market cap (in EUR)
17,199.70 m
Country
Switzerland
Sector
Healthcare
Dividend yield
1.23%
Overview
Description
Sandoz Group AG engages in focusing on generic pharmaceuticals and bio similar medical products. It acquires, manages and sells investments and intellectual property in the healthcare and medical device industry and conducts all business at home and abroad. The firm can acquire, sell, debit and manage interests in other companies, intellectual property rights and real estate at home and abroad, as well as establish branches and subsidiaries at home and abroad. The company was founded on January 17, 2022 and is headquartered in Rotkreuz, Switzerland.
Healthcare Biopharmaceuticals Other Biopharmaceuticals Switzerland
Financials
Key metrics
| Market capitalisation, EUR | 17,199.70 m |
| EPS, EUR | - |
| P/B ratio | 2.14 |
| P/E ratio | 246.02 |
| Dividend yield | 1.23% |
Income statement (2024)
| Revenue, EUR | 9,581.99 m |
| Net income, EUR | 0.00 m |
| Profit margin | 0.00% |
What ETF is Sandoz Group in?
There are 238 ETFs which contain Sandoz Group. All of these ETFs are listed in the table below. The ETF with the largest weighting of Sandoz Group is the iShares SMIM (CH).
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
